NCT01293396

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

Comparison of the Impact of Biphasic Insulin Aspart 30 (BiAsp 30), Biphasic Insulin Aspart 70 (BiAsp 70) and Insulin Aspart on Postprandial Glucose and Lipid Metabolism During Two Consecutive Meals in Type 2 Diabetics.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Medical University of Graz · Academic / Other
• Sex: All
• Age: 35 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to investigate meal-related treatment with either premixed Insulin Aspart 30, Aspart 70 and Aspart with regard to postprandial glucose, triglyceride and free fatty acids excursions after a standard breakfast and lunch.

Detailed description

Whereas the effects of each of the established types of insulin (remixed Insulin Aspart 30, Aspart 70 and Aspart) have been shown before, their specific glucose and lipid lowering capacities have so far not been investigated in a simulated physiological situation.

Conditions

• Type 2 Diabetes

Interventions

Type	Name	Description
DRUG	Insulin Aspart	Patients received insulin aspart before breakfast and before lunch.
DRUG	Insulin Aspart 30	Patients received biphasic insulin aspart 30 before breakfast and before lunch.
DRUG	Insulin Aspart 70	Patients received biphasic insulin aspart 70 before breakfast and before lunch.

Timeline

• Start date: 2010-06-01
• Primary completion: 2011-02-01
• Completion: 2011-03-01
• First posted: 2011-02-10
• Last updated: 2021-06-30
• Results posted: 2021-06-30

Locations

1 site across 1 country: Austria